night sweats tirzepatide Does Mounjaro cause sweats? What the evidence shows Night Sweats: Causes and Treatments

Planning for the ongoing investment in health and receiving support throughout the treatment journey is key

At ITALIO Pharmaceuticals, we are committed to supporting India's healthcare ecosystem by delivering quality pharmaceutical solutions and promoting responsible medicine use

Primary candidates for GLP-1 therapy include: Patients with type 2 diabetes and inadequate glycemic control despite metformin therapy Individuals with type 2 diabetes and established atherosclerotic cardiovascular disease Patients with type 2 diabetes and multiple cardiovascular risk factors (hypertension, dyslipidemia, obesity) Adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities Patients with metabolic syndrome who have not achieved adequate risk factor control with lifestyle modification For patients with dyslipidemia, GLP-1 agents may be particularly valuable when combined with statin therapy in those who have not reached LDL-C goals or who have persistent hypertriglyceridemia despite statin treatment

And 63 percent saw their liver fat and inflammation go down, compared with 34 percent on the placebo

Journal of Investigative Dermatology , 126(8), 1869-1878

A meal planning app that lets you set calorie and protein targets removes much of the daily guesswork by creating balanced meals that fit your goals